0001493152-21-023910.txt : 20210927 0001493152-21-023910.hdr.sgml : 20210927 20210927193142 ACCESSION NUMBER: 0001493152-21-023910 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210924 FILED AS OF DATE: 20210927 DATE AS OF CHANGE: 20210927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINDSTROM RICHARD L MD CENTRAL INDEX KEY: 0001242177 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 211283169 MAIL ADDRESS: STREET 1: 2811 WESTWOOD PL CITY: WAYZATA STATE: MN ZIP: 55391 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW HEALTH, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 FORMER COMPANY: FORMER CONFORMED NAME: Bywater Resources, Inc DATE OF NAME CHANGE: 20060421 4 1 ownership.xml X0306 4 2021-09-24 0 0001360214 HARROW HEALTH, INC. HROW 0001242177 LINDSTROM RICHARD L MD C/O HARROW HEALTH, INC. 102 WOODMONT BLVD. SUITE 610 NASHVILLE TN 37205 1 0 0 0 Common Stock 2021-09-24 4 S 0 3900 10.04 D 66100 I See Footnote Common Stock 100000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021 and was terminated by the reporting person on September 24, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.08, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents shares held by the Lindstrom Family Limited Partnership No. 2, a limited partnership of which the reporting person is the general partner. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). /s/ Richard L. Lindstrom 2021-09-27